Citations

Clear

16280 citation(s) found for "Yu, David".

Risk of Relapse Post Reduced Intensity Conditioning Allogeneic Stem Cell Transplant in Patients With High‐Risk Myeloid Neoplasms Based on GvHD Prophylaxis: PTCy
Hassan, Khalil , Baranwal, Anmol , Kassis, Al Rabee, Braun, Jade, Bartoo, Gabriel , Hefazi, Mehrdad , Matin, Aasiya , Mangaonkar, Abhishek A. , Shah, Meera , Litzow, Mark R. , Dingli, David , Alkhateeb, Hassan B. , Wolf, Robert, Hefazi, Mehrdad , Mangaonkar, Abhishek A. , Shah, Mithun V , Litzow, Mark R. , Dingli, David , Alkhateeb, Hassan B , Baranwal, Anmol , Braun, Jade, Wolf, Robert Christian , Hogan, William J.

Mayo Clinic

American Journal of Hematology | September 4, 2025 | Volume: 100 | Issue: 11 | Pages: 2134-2139

10.1002/ajh.70059 | PMID 40905640 Get It

An Uncommon Cause of Angina
Majdalany, David , Blickenstaff, Elaina A. , Marcotte, François , Anderson, Jason , Majdalany, David S , Anderson, Jason H. , Anderson, Jason H., Blickenstaff, Elaina A.

Mayo Clinic

Diagnostics | September 4, 2025 | Volume: 15 | Issue: 17 | Pages: 2241

10.3390/diagnostics15172241 | PMID 40941728 Get It

Coronary anomalies, although rare, should be considered when young patients present with angina. Clinical suspicion and multi-modality imaging including coronary angiography and tomographic imaging should be pursued for symptomatic patients such as the one we are presenting with anomalous right coronary artery from the pulmonary artery. She was promptly referred for surgical intervention with re-implantation of the right coronary artery onto the aorta.
Domain-specific physical activity and mental health: an updated systematic review and multilevel meta-analysis in a combined sample of 3.3 million people
Sousa, Geovan Menezes de , Baker, Thea , Liddelow, Caitlin , Babic, Mark , France‐Ratcliffe, Madeleine , Guagliano, Justin M. , Tremaine, Ella M , Booker, Bridget , Gargioli, Davide , Bannell, Daniel J , Bao, Ran , Brooks, Cristy , Vella, Stewart A. , Lonsdale, Chris , Teychenne, Megan , Sousa, Geovan M , Liddelow, Caitlin , Christie, Hannah E. , Lubans, David R , Swann, Christian , Vella, Stewart A , Lonsdale, Chris , White, Rhiannon L , Chauntry, Aiden J. , Santos, Alexandre

Mayo Clinic

British Journal of Sports Medicine | September 3, 2025 | Volume: 60 | Issue: 4 | Pages: 267-285

10.1136/bjsports-2025-109806 | PMID 40903203 Get It

Objective To update, synthesise and provide meta-analytical evidence of the associations between domain-specific physical activity (PA) and mental health and mental ill-health outcomes. Design Systematic review and multilevel meta-analysis. Data sources In March 2024, we systematically searched five databases. Eligibility criteria Methods employed replicated those of a previous review in 2017. All studies examining associations between domain-specific PA and specified mental health outcomes were included. Results 372 studies met inclusion criteria and 361 were included in the meta-analysis. Across the 372 studies (combined sample size of 3 323 711), 338 examined leisure-time PA, 54 work-related PA, 72 transport-related PA, 44 household PA, 5 school sport and 8 physical education. Multilevel meta-analyses showed that leisure-time PA (r=0.205, 95% CI 0.157 to 0.253), transport-related PA (r=0.138, 95% CI 0.042 to 0.231) and household PA (r=0.096, 95% CI 0.025 to 0.165) were positively associated with mental health . Leisure-time PA (r=−0.149, 95% CI −0.189 to –0.11) and school sport (r=−0.096, 95% CI −0.115 to –0.077) were inversely associated with mental ill health . However, work-related PA (r=0.134 95% CI 0.069 to 0.199) was positively associated with mental ill health . Conclusion The direction of the association between PA and mental health/mental ill health is dependent on the domain in which PA occurs. Promoting PA for leisure purposes is likely to yield the greatest benefits for both promoting mental health and preventing mental ill health. As such, leisure-time PA should be prioritised in messaging, guidelines and interventions/programmes designed to support mental health through PA. PROSPERO registration number CRD42024510303.
ACR–ABS–ACNM–ARS–SIR–SNMMI Practice Parameter for Radioembolization of Liver Malignancies
Johnson, Thor, Spieler, Benjamin , Toskich, Beau , Wang, David S. , Russo, Suzanne , Sharma, Navesh , Wright, Chadwick , Farsad, Khashayar , Muzahir, Saima , Chundury, Anupama , Subramaniam, Rathan M. , Caplin, Drew M. , Schechter, Naomi R., Toskich, Beau B. , Hathout, Lara , Russo, Suzanne , Kim, Charles , Kappadath, Srinivas Cheenu , Parent, Ephraim E. , Sio, Terence T. , Mercier, Gustavo , Ghesani, Munir V. , Small, William

Mayo Clinic

American Journal of Clinical Oncology | September 3, 2025 | Volume: 49 | Issue: 1 | Pages: 10-24

10.1097/coc.0000000000001234 | PMID 40899409 Get It

Objectives: The practice parameter was revised collaboratively by the American College of Radiology (ACR), the American Brachytherapy Society (ABS), the American College of Nuclear Medicine (ACNM), the American Radium Society (ARS), the Society of Interventional Radiology (SIR), and the Society of Nuclear Medicine and Molecular Imaging (SNMMI). This document summarizes current evidence-based guidelines for the administration of Yttrium radioembolic therapy to the liver, including training requirements, evidence-based guidelines for administration, and safe practice for administration. Methods: This practice parameter was revised according to the process described under the heading The Process for Developing ACR Practice Parameters and Technical Standards on the ACR website (https://www.acr.org/ClinicalResources/Practice-Parameters-and-Technical-Standards) by the Committee on Practice Parameters—Interventional and Cardiovascular Radiology of the ACR Commission on Interventional and Cardiovascular, Committee on Practice Parameters and Technical Standards—Nuclear Medicine and Molecular Imaging of the ACR Commission on Nuclear Medicine and Molecular Imaging and the Committee on Practice Parameters—Radiation Oncology of the ACR Commission on Radiation Oncology in collaboration with the ABS, the ACNM, the ARS, the SIR, and the SNMMI. Results: This review seeks not to be a comprehensive discussion of radiotherapy to the liver, but rather, seeks to provide a parameter for safe and effective therapy. We discuss the qualifications of physicians involved in this therapy, basic indications, contraindications, procedural work-up, safe-handling, and regulatory requirement for the administration of selective internal radiation therapy to patients that are likely to benefit. The goal of this document is not to define which patients are best treated by these therapies, as this is best determined for individual patients after multidisciplinary review. A consistent and evidence-based approach to therapy, however, would benefit all patients who are offered this therapy. This document seeks to provide a framework for current best practices for the administration of the 2 currently available radioembolization devices. Conclusions: As Yttrium-90 radiotherapy to the liver occupies a growing role in the treatment of primary and metastatic liver cancer, this review seeks to assist clinicians of all involved specialties to optimize the efficacy and safety of these procedures.
Was It Worth It? Response Data from >650 US and International Participants in Chemoprevention Trials
Zahrieh, David M. , Strand, Carrie , Limburg, Paul J. , Jatoi, Aminah , Mandrekar, Sumithra J. , Zahrieh, David , Strand, Carrie A , Limburg, Paul J

Mayo Clinic

Cancer Prevention Research | September 3, 2025 | Volume: 19 | Issue: 1 | Pages: 11-23

10.1158/1940-6207.capr-25-0180 | PMID 40899448 Get It

Abstract The aim was to assess whether subject’s participation in early-phase chemoprevention trials was satisfactory and identify features associated with subjects’ satisfaction. Thirteen trials that investigated a range of candidate agents from 2006 to 2021 by the Cancer Prevention Network were included. The five-item “Was It Worth It?” (WIWI) questionnaire was administered to all subjects at the end of each trial’s intervention or at early termination. Satisfied overall was defined as a participant response of “yes” to the first three questions. Six hundred ninety-one participants from the United States, Canada, Puerto Rico, and Honduras enrolled on a trial. Six hundred fifty-two (94.4%) completed the WIWI questionnaire. Of these, 493 (75.6%) were White, non-Hispanic/Latino; 39 (6.0%) Black, non-Hispanic/Latino; 98 (15.0%) Hispanic/Latino; and 8 (1.2%) of another race/ethnicity. One hundred ninety-three were women (29.6%), 121 (17.5%) were ≥65 years, and 517 (79.3%) participated in a placebo-controlled trial. Eighty-five percent indicated being satisfied overall. Compared with White, non-Hispanic/Latino, the odds of not satisfied overall were 2.96 times higher for Black/Asian/>1 race, non-Hispanic/Latino (P < 0.001) and 0.40 times lower for Hispanic/Latino (P = 0.004). The odds of not satisfied overall was 1.9 times higher when the number of preintervention adverse events experienced was ≥1 (P = 0.012), 1.8 times higher when the percentage of the intervention duration with adverse events was >5% (P = 0.024), and 7.4 times higher for subjects who terminated the intervention early (P < 0.001). These findings can inform the design of future chemoprevention trials and help investigators improve accrual, retention, adherence, and diversity in this underexplored research setting. Prevention Relevance: The five-item “WIWI?” questionnaire, which captures the participant-reported experience of trial participation, gives the subject a voice in the development of new chemopreventative agents. This study in 652 subjects looked at satisfaction with participation in early-phase chemoprevention trials for higher-risk, cancer-free men and women. See related Spotlight, p. 7
A233 Impact of aspiration catheter inner diameter on first-pass effect: a systematic review and meta-analysis
Reda, Abdullah, Maroufi, Seyed Farzad , Ramanathan, Kadirvel, Kallmes, David F. , Jazayeri, Seyed Behnam , Cortese, Jonathan , Hamouda, Abdelrahman M. , Ghozy, Sherief , Ramanathan, Kadirvel

Mayo Clinic

8. Ischemic stroke – 8.13 Future directions in stroke management | September 3, 2025 | Volume: No volume available | Issue: No issue available | Pages: A87-A88

10.1136/jnis-2025-esmint.134 Get It

A151 Real-world experience of the large 6–50 aperio stent-retriever: evaluation of effectiveness and safety
Dunkerton, Sophie, Flood, R. H., Cox, Anthony , Wareham, James , Minks, David , Ghozy, Sherief , Mortimer, Alex , Flood, Richard

Mayo Clinic

8. Ischemic stroke – 8.1 Innovative therapies for ischemic stroke | September 3, 2025 | Volume: No volume available | Issue: No issue available | Pages: A73.2-A74

10.1136/jnis-2025-esmint.108 Get It

Improving immune‐related health outcomes post‐cesarean birth with a gut microbiome‐based program: A randomized controlled trial
Nieto, Pamela A. , Nakama, Claudia , Trachsel, Julian , Goad, David, Soderborg, Taylor K., Orlandi, Amy, Yuan, Qian , Song, Elisa Hae-Jung, Hoy, Cheryl Sew, Sukhum, Kimberley V. , Yuan, Qian , Tan, Danielle Shea, Orlandi, Amy, Mueller, Noel Theodore , Mars, Ruben A.

Mayo Clinic

Pediatric Allergy and Immunology | September 3, 2025 | Volume: 36 | Issue: 9 | Pages: No page available

10.1111/pai.70182 | PMID 40898384 Get It

AbstractBackgroundInfants born via Cesarean section (C‐section) often have a distinct gut microbiome and higher risks of atopic and immune‐related conditions than vaginally delivered infants. We evaluated whether a microbiome‐based program could shift gut microbiome composition and improve microbiome‐associated health outcomes in C‐section born infants.MethodsThis open‐label, randomized, controlled trial included full‐term C‐section‐born infants aged 0–3 months, randomized to an intervention (n = 25) or control arm (n = 29). Over 6 months, the intervention arm received two microbiome reports, personalized recommendations based on their microbiome, educational materials, and coaching calls focused on microbiome health. Parents reported health conditions via surveys. Primary outcome: Difference between study arms in relative abundance of key gut microbiome taxa and functional genes. Other outcomes: Changes in a C‐section index—a taxonomy‐based metric comparing C‐section‐associated taxa to vaginally‐associated taxa—and prevalence of atopic conditions.ResultsCompared to controls, the intervention arm had higher Bifidobacterium (p = .025, q = .121) and higher abundance of genes associated with human milk oligosaccharide degradation (e.g., α‐L‐fucosidase, p = .019, q = .046) at timepoint 2. In the intervention arm, the C‐section index decreased to a level similar to vaginally born infants (p = .807, q = .807). At the end of the intervention, atopic dermatitis prevalence was lower in the intervention arm than in controls (odds ratio, 0.17 [95% CI, 0.023–0.723], p = .031).ConclusionA personalized microbiome‐based program can modulate the gut microbiome of C‐section‐born infants and may reduce the risk of atopic conditions (ClinicalTrials.gov: NCT06424691).
Palliative Care Resource Utilization in Patients With Prion Disease
Zayat, Roaa , Piura, Yoav , Appleby, Brian S. , Robinson, Maisha T. , Day, Gregory S. , Day, Gregory S , Appleby, Brian

Mayo Clinic

Neurology | September 2, 2025 | Volume: 105 | Issue: 6 | Pages: No page available

10.1212/wnl.0000000000214076 | PMID 40893060 Get It

The assessment and management of patients with type 2 myocardial infarction: an international Delphi study
Taggart, Caelan , Ferry, Amy V. , Chapman, Andrew , Schulberg, Stacey D. , Bularga, Anda , Wereski, Ryan, Boeddinghaus, Jasper, Kimenai, Dorien M , Lowry, Matthew T.H. , Daniels, Lori B. , French, J. , Gaggin, Hanna K. , Huynh, T. , Jacquin, Laurent , Jaffe, A S, Jernberg, Tomas , Koronowski, Ran, McCarthy, Cian P. , McCord, James , Mickley, Hans , Mueller, Christian , Newby, L. Kristin , Parsonage, William , Smith, Stephen W., Sandoval, Yader, Smilowitz, Nathaniel R. , Thygesen, Kristian , Mills, Nicholas L. , Boeddinghaus, Jasper , Cullen, Louise , Jernberg, Tomas , Mamas, Mamas , Mueller, Christian , Raphael, Claire , White, Harvey Douglas , Lindahl, Bertil , Thygesen, Kristian , Mills, Nicholas L , Daniels, Lori B , Boeddinghaus, Jasper , Chew, Derek P. , Cullen, Louise , Devereaux, P.J. , Mamas, Mamas A. , Morrow, David A. , Raphael, Claire E. , Smer, Aiman Miloud , Sandoval, Yader , Eggers, Kai M. , Lindahl, Bertil

Mayo Clinic

European Heart Journal - Quality of Care and Clinical Outcomes | September 2, 2025 | Volume: 11 | Issue: 8 | Pages: 1421-1430

10.1093/ehjqcco/qcaf069 | PMID 40905366 Get It

Abstract Aims Type 2 myocardial infarction due to myocardial oxygen supply–demand imbalance is associated with poor outcomes. There are no guidelines to inform care for these patients. The consensus on the assessment and management of type 2 myocardial infarction is gained. Methods and results An international e-Delphi study including experts in type 2 myocardial infarction identified through systematic review was conducted. Participants were asked to describe their approach to (i) definition and diagnosis, (ii) risk stratification, (iii) assessment of coronary artery disease and cardiac function, (iv) specialty management, (v) treatment and secondary prevention, and (vi) communication and rehabilitation. Statements generated in round one were circulated, with consensus defined a priori as ≥70% agreement on a 5-point Likert scale. Where no consensus was reached, statements were amended and recirculated for a final round. The response rate was 56% (38/68), 54% (37/68), and 72% (49/68) in the first, second, and third rounds, respectively. Following the first round, 67 unique statements were generated across six domains. Overall, consensus was achieved on 64% (43/67) of statements. Consensus was achieved for 42% (5/12) of statements on the diagnosis of type 2 myocardial infarction, 75% (3/4) on risk stratification, 50% (9/18) on the assessment of coronary artery disease and cardiac function, 60% (6/10), on specialty management, 100% (9/9) on treatment and secondary prevention, and 79% (11/15) on communication and rehabilitation. Conclusion Consensus was obtained across a number of domains for the assessment and management of patients with type 2 myocardial infarction. However, there was limited agreement amongst experts on the diagnostic criteria, which may benefit from refinement.